ICM
CPAY icon

Invenomic Capital Management’s Corpay CPAY Stock Holding History

Invenomic Capital Management’s Portfolio CPAY Stock Details CPAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,364
Closed -$2.36M – 201
2023
Q4 		$2.36M Sell
8,364
-161,834
-95% -$40.2M 0.11% 139
2023
Q3 		$43.5M Sell
170,198
-74,716
-31% -$19.5M 1.83% 16
2023
Q2 		$61.5M Sell
244,914
-3,510
-1% -$800K 3.12% 3
2023
Q1 		$52.4M Buy
+248,424
New +$50.4M 2.96% 1

Other funds holding CPAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invenomic Capital Management's CPAY Position: Q1 2024 in Review

Invenomic Capital Management sold out of Corpay (CPAY) in Q1 2024, closing a stake of 8,364 shares — an estimated $2.36M sold.

Invenomic Capital Management first reported a position in CPAY in Q1 2023 and held it in 4 quarters. The position peaked at $61.5M in Q2 2023. 568 funds tracked by Wall St. Rank hold CPAY as of Q1 2024.

  • Invenomic Capital Management reported no remaining Corpay position as of Q1 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 8,364 Corpay shares in Q1 2024, an estimated $2.36M.
  • Invenomic Capital Management first reported a position in Corpay in Q1 2023 and held it in 4 quarters.
  • Invenomic Capital Management's Corpay position peaked at $61.5M in Q2 2023.
  • 568 funds tracked by Wall St. Rank held Corpay as of Q1 2024.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.